AbCellera Biologics (ABCL)
(Delayed Data from NSDQ)
$3.01 USD
+0.04 (1.35%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $3.01 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/6/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.14 |
Last EPS Surprise | 12.50% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.60 |
Next Year | -0.72 |
EPS (TTM) | -0.52 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.11M | 11.03M | 43.13M | 64.07M |
# of Estimates | 6 | 5 | 6 | 7 |
High Estimate | 11.57M | 15.14M | 53.64M | 123.59M |
Low Estimate | 8.20M | 9.38M | 36.56M | 45.22M |
Year ago Sales | 10.06M | 6.60M | 38.03M | 43.13M |
Year over Year Growth Est. | 0.48% | 67.15% | 13.42% | 48.56% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.15 | -0.60 | -0.72 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.15 | -0.14 | -0.56 | -0.68 |
High Estimate | -0.14 | -0.14 | -0.56 | -0.60 |
Low Estimate | -0.19 | -0.19 | -0.73 | -1.03 |
Year ago EPS | -0.11 | -0.10 | -0.51 | -0.60 |
Year over Year Growth Est. | -45.45% | -50.00% | -17.65% | -20.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 1 | 1 | 1 |
Down Last 30 Days | 0 | 1 | 1 | 1 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.15 | -0.60 | -0.72 |
7 Days Ago | -0.16 | -0.15 | -0.60 | -0.72 |
30 Days Ago | -0.16 | -0.15 | -0.60 | -0.72 |
60 Days Ago | -0.16 | -0.15 | -0.60 | -0.73 |
90 Days Ago | -0.17 | -0.16 | -0.66 | -0.70 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.14 | -0.57 | -0.60 |
Zacks Consensus Estimate | -0.16 | -0.15 | -0.60 | -0.72 |
Earnings ESP | 0.00% | 7.90% | 5.63% | 17.13% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.14 | -0.17 | -0.10 | -0.11 | NA |
Estimate | -0.16 | -0.14 | -0.14 | -0.13 | NA |
Difference | 0.02 | -0.03 | 0.04 | 0.02 | 0.01 |
Surprise | 12.50% | -21.43% | 28.57% | 15.38% | 8.76% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more